Brief: Cerevel Therapeutics Reports First Quarter 2022 Financial Results And Business Updates

Cerevel Therapeutics Holdings

10/05/2022 11:36

May 10 (Reuters) - Cerevel Therapeutics Holdings Inc
 CERE.O :
    * CEREVEL THERAPEUTICS REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS AND BUSINESS UPDATES
    * CEREVEL THERAPEUTICS HOLDINGS - ON TRACK TO INITIATE TWO
PARALLEL ADEQUATELY-POWERED PHASE 2 TRIALS OF EMRACLIDINE IN
SCHIZOPHRENIA BY MID-YEAR 2022
    * CEREVEL THERAPEUTICS HOLDINGS - CASH, CASH EQUIVALENTS AND
MARKETABLE SECURITIES ARE EXPECTED TO CONTINUE TO SUPPORT
OPERATIONS INTO 2024
    * CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES AS OF
MARCH 31,
2022, WERE $550.9 MILLION
    * QTRLY LOSS PER SHARE $0.46
    * Q1 EARNINGS PER SHARE VIEW $-0.43 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX61ddtz 
Further company coverage:  CERE.O 

 ((Reuters.Briefs@thomsonreuters.com;))